Related Experiment Video
Updated: Aug 24, 2026

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
Resolution of macroprolactinoma-induced symptomatic hydrocephalus following cabergoline therapy
Pedro Iglesias1, Lucía Pérez Macho, Juan J Díez
1Departments of Endocrinology and Neurology, Hospital General, Segovia, Spain. piglesias@hgse.sacyl.es
Abstract:
A 71-year-old man was referred because of memory loss. Magnetic resonance imaging showed a pituitary macroadenoma associated with hydrocephalus. Marked hyperprolactinaemia was present. After 2 months of cabergoline therapy, magnetic resonance imaging showed tumour shrinkage with resolution of the hydrocephalus. We report, for the first time, the adequate and rapid clinical response of a macroprolactinoma-induced symptomatic hydrocephalus in an elderly man to a low and once-a-week dose of cabergoline therapy. Medical therapy with this dopamine agonist in this particular patient was so effective that ventriculo-peritoneal shunting could be avoided.
